Visual loss in giant cell arteritis 3 weeks after steroid initiation

Area of Science:

• Rheumatology
• Ophthalmology
• Internal Medicine

Background:

• Giant cell arteritis (GCA) is the most common form of systemic vasculitis affecting older adults.
• Prompt treatment with oral glucocorticoids is crucial for preventing vision loss, a common complication of GCA.
• Despite treatment, irreversible blindness can occur, necessitating a review of management strategies.

Observation:

• A 77-year-old male patient was diagnosed with GCA and initiated on oral steroid therapy.
• The patient subsequently developed irreversible bilateral blindness.
• This outcome occurred despite the established treatment protocols for GCA.

Findings:

• The case underscores the potential for vision loss even with timely diagnosis and treatment of GCA.
• Diagnostic delays, suboptimal steroid dosing, and the interpretation of visual symptoms are critical factors.
• Ophthalmological signs require careful evaluation in the context of GCA management.

Implications:

• This case highlights the need for vigilance regarding visual symptoms in GCA patients, both at diagnosis and during treatment.
• It emphasizes the importance of optimizing steroid dosing and minimizing diagnostic delays to prevent severe complications like blindness.
• Further research into adjunctive therapies or refined treatment protocols may be warranted to improve visual outcomes in GCA.